Registered number: N1605880 LILAC CANCER SUPPORT LTD DIRECTORS. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2025 cAmcg O"PIAGANM¢GLJP4CHEY & CO. Lilac Cancer Support Ltd Contents Page Company Information Directors, Report Accountant's Report Income and Expenditure Account Balance Sheet Notes to the Financial Statements The following pages do not forni part of the statutory accounts- Detsiled Incorne and Expenditure Account Lilac Cancer Support Ltd Company Information For The Year Ended 31 January 2025 Directors Mrs Bernadette Morgan Mr Eamon Morgan Mrs Anne Walsh Mrs Julie Ann McAlister Mrs Cordelia Mccarragher Mr Daniel O'Hagan Company Number N1605880 Reglstered Office 2nd Floor Loy Buildings Loy Street Cookstown Tyrone BT80 8PE Accountants O'Hagan McGlinchey & Co 36 Dungannon Road Coalisland Dungannon Tyrone BT71 4HP Page I Lilac Cancer Support Ltd Company No. N1605880 Directors. Report For The Year Ended 31 January 2025 The directors present their report and the financial statements for the year ended 31 January 2025. Directors The directors who held offfice during the year were as follows= Mrs Bernadette Morgan Mr Eamon Morgan Mrs Anne Walsh Mrs Julie Ann McAlister Mrs Cordelia Mccarragher Appointed 1810512024 Mr Daniel O'Hagan Appointed OIJ0512024 statement of Director5. Responsibilities The directors are responsible for preparing the Directors, Report and the financial statements in accordance with applicable law and regulations. Company law requires the dirertors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing the financial statements the directors are ￿qUired to= selert suitable accounting policies and then apply them consistently: make judgments and accounting estimates that are reasonable and prudent- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The directors are responsible for the Maintenan￿ and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom goveming the p￿paratIOn and dissemination of financial statements may differ from legislation in other jurisdictions. Small Company Rules This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. On behalf of the board Mrs Bernadette Morgan Mrs Anne Walsh Director 14th April 2025 Director Page 2 Lilac Cancer Support Ltd Accountant's Report For The Year Ended 31 January 2025 Report to the dirertors on the preparation of the unaudited 5tstutory accounts of Lilac Cancer Support Ltd for the year ended 31 January 2025 In order to assist you to fulfil your duties under the Companies Act 2006, 1 have prepared for your approval the accounts of Lilac Cancer Support Ltd for the year ended 31 January 2025 which comprise the Income and Expenditure Account, the Balance Sheet and the related notes from the accounting records and from information and explanations you have given to us. As a practising member of the Institute of Financial Accountants (IFA). we are subjert to its ethical and other professional requirements which are detailed at https=//www.ifa.org.uVabout-us/acting-in-the-public-interest/memberregulations. This report is made solely to the dirertors of Lilac Cancer Support Ltd. as a body, in accordance with the terms of our engagement letter dated 19 March 2024. Our work has been undertaken solely to prepare for your approval the accounts of Lilac Cancer Support Ltd and state those matters that we have agreed to state to the directors of Lilac Cancer Support Ltd, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Lilac Cancer Support Ltd and its directors. a5 a body. for our work or for this report. It is your duty to ensure that Lilac Cancer Support Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Lilac Cancer Support Ltd. You consider that Lilac Cancer Support Ltd is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit of the accounts of Lilac Cancer Support Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or infomiation and explanations you have given to us and we do not, therefore, express any opinion on the financial statements. Signed 14th April 2025 O'Hag3n McGlinchey & Co 36 Dungannon Road Coalisland Dungannon Tyrone BT71 4HP Page 3 Lilac Cancer Support Ltd Income and Expenditure Account For The Year Ended 31 January 2025 2025 2024 Notes TURNOVER Cost of sales 158,372 (95,785) 142,053 {96,798) GROSS SURPLUS 62,587 45,255 Administrative expenses other operating income (51.640) 12,888 (56,894) 10,433 OPERATING SURPLUS/(DEFICIT) AND SURPLUS/(DEFICIT) FOR THE FINANCIAL YEAR 23,835 (1,206) The notes on pages 6 to 7 form part of these financial statements. Page 4 Lilac Cancer Support Ltd Balance Sheet As At 31 January 2025 2025 2024 Note5 FIXED ASSETS Tangible Assets 22,456 30,777 22,456 30,777 CURRENT ASSETS Stocks Cash at bank and in hand 5.110 118.466 5.475 85,593 123.576 91,068 Creditors: Amounts Falling Due Within One Year (1.642) (1,290) NET CURRENT ASSETS {LIABILThIES) 121,934 89,778 TOTAL ASSETS LESS CURRENT LIABILITIES 144,390 120,555 NET ASSETS 144,390 120,555 Incorne and Expenditure Account 144,390 120,555 MEMBERS. FUNDS 144,390 120,555 For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with sertion 476 of the Companies Act 2006. The director5 acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regirne. On behalf of the board Mrs Bernadette Morgan Mrs Anne Walsh D1￿ctOr 14th April 2025 Director The notes on pages 6 to 7 forrn part of these financial statements. Page 5 Lilac Cancer Support Ltd Notes to the Financial Statements For The Year Ended 31 January 2025 l. General Information Lilac Cancer Support Ltd is a private company. limited by guarantee, incorporated in Northern Ireland, registered number N1605880. The registered office is 2nd Floor Loy Buildings. Loy Street, Cookstown. Tyrone, BT80 8PE. 2. Accounting Policies 2. 1. Basis of Preparation of Financial Statements The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section IA Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Aci 2006. 2.2. Turnover Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns. rebates and other similar allowances. Sale of goods Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods. Rendering of services Turnover from the rendering of services is recognised by reference to the stage of completion of the contrart. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Tumover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably. 2.3. Tangible Fixed A55ets and Depreciation Tangible fixed assets are measured at C05t less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases.. Plant & Machinery Motor Vehicles Fixtures & Fittings 250/0 Reducing Balance 250/0 Reducing Balance 25% Reducing Balance 2.4. stocks and Work in Progress stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflerted in the accounts on a contrart by contrart basi5 by recording turnover and related costs as contrart activity progresses. Average Number of Employees Average number of employees, including directors. during the year was- 4 (2024- 5) Tangible Assets Plant & Machinery Motor Vehicles Fixtures & Fittings Total Cost As at l February 2024 28,118 41,212 16,945 86,275 As at 31 January 2025 28,118 41,212 16,945 86,275 Depreciation As at l February 2024 Provided during the period 17.765 2.786 24,147 4,373 13,586 1,162 55,498 8,321 As at 31 January 2025 20,551 28,520 14,748 63,819 .CONTINUED Page 6 Lilac Cancer Support Ltd Notes to the Financial Statements (continued) For The Year Ended 31 January 2025 Net Book Value As at 31 January 2025 7.567 12,692 2,197 22,456 As at l February 2024 10,353 17,065 3,359 30,777 Stocks 2025 2024 Finished goods 5,110 5,475 6. Creditors: Amounts Falling Due Within One Year 2025 2024 Other taxes and social security Accruals and deferred income 842 590 800 700 1,642 1,290 Reserves Included in the reverves figure is £60,000 that has been set aside to cover operational costs for a 6 month period. 8. Company limited by guarantee The company is limited by guarantee and has no share capital. Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1. Restricted Funds At the 31st january 2025 there was a Grant from, The Community Fund, of £14,160 included in reserves. This will be spent during the year ended 315t January 2026. Page 7 Lilac Cancer Support Ltd Detailed Income and Expenditure Account For The Year Ended 31 January 2025 2025 2024 TURNOVER Shop Takings Rental income Grants and subsidies received Other trading income 91,088 450 60,981 5.853 80,023 1,350 51,208 9,472 158,372 142,053 COST OF SALE5 Opening Stock - finished goods Activity costs Helpers Wages and salaries Employers pensions - defined contribution schemes Closing stock - finished goods 5.475 14.593 12,878 66.297 1.652 (5.110) 5,500 13,358 14,126 68.106 1,183 (5,475) (95,785) (96,798) GROSS SURPLUS 62,587 45,255 Administrative Expenses Rent Rates Light and heat Vehicle running costs Repairs, renewals and maintenance Insurance Printing, postage and stationery Telecommunications and data costs 20.157 785 2.700 5.717 1.497 3.865 2.123 4.033 1.532 689 18,969 577 1,791 6,184 7,947 3,850 1,369 3,557 1,561 670 Accountancy fees Subscriptions Bank charges Depreciation of plant and machinery Depreciation of motor vehicles Depreciation of fixtures and fittings Sundry expenses 134 2.788 4.372 1.162 86 146 3,451 5,689 1,120 13 (51,640) (56,894) Other Operating Income Fundraising & donations 12.888 10.433 12,888 10,433 OPERATING SURPLUS/(DEFICIT) AND SURPLUS/(DEFICIT) FOR THE FINANCIAL YEAR 23,835 (1,206) Page 8